SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-22-005546
Filing Date
2022-08-10
Accepted
2022-08-09 17:50:16
Documents
48
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20220630_10q.htm   iXBRL 10-Q 767715
2 EXHIBIT 31.1 ex_405544.htm EX-31.1 9864
3 EXHIBIT 31.2 ex_405545.htm EX-31.2 9905
4 EXHIBIT 32.1 ex_405546.htm EX-32.1 5108
  Complete submission text file 0001171843-22-005546.txt   3394802

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20220630.xsd EX-101.SCH 28333
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20220630_cal.xml EX-101.CAL 26327
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20220630_def.xml EX-101.DEF 205965
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20220630_lab.xml EX-101.LAB 185737
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20220630_pre.xml EX-101.PRE 224494
42 EXTRACTED XBRL INSTANCE DOCUMENT xbit20220630_10q_htm.xml XML 453299
Mailing Address 5217 WINNEBAGO LANE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 221149693
SIC: 2834 Pharmaceutical Preparations